Possibia

2008838

Last Update Posted: 2013-12-11

Recruiting has ended

All Genders

accepted

18 Years +

38 Estimated Participants

No Expanded Access

Interventional Study

Does not accept healthy volunteers

Effects of Synbiotic Supplementation in Metabolic Syndrome

To evaluate the effects of synbiotic supplementation on insulin resistance, and lipid profile in subjects with metabolic syndrome, in a randomized, double-blind, placebo-controlled pilot study, 38 subjects with metabolic syndrome will be supplemented with either synbiotic or placebo capsules twice/day for 28 weeks. Both the synbiotic (G1) and the placebo (G2) groups will be advised to follow an energy balanced diet and physical activity recommendations. Parameters related to metabolic syndrome and insulin resistance will be measured every 7 weeks during the study course.

Eligibility

Relevant conditions:

Metabolic Syndrome

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

No valid contacts available

Data sourced from ClinicalTrials.gov